amortization) were Thai Baht 195.04 million in 2019 or 51.88% more than Thai Baht 128.42 million in 2018. The variance was mostly due to an increase in employee expenses and sales promotion expenses. EBITDA
-year from Baht 27.64 million in 1Q18. The variance was mostly due to an increase in number of patients, depreciation and employee management expenses. EBITDA increased by 112.55% year- over-year to Baht
variance was mostly due to an increase in employee expenses. Profit to equity holders of the company in 1Q20 decreased by 74.83% year‐over‐year to THB 11.25 million from THB 44.70 million in
and its subsidiaries performance are the comparative performance of the year of 2017 and the year of 2016; Table: Operating Results (Unit: Million Baht) Items Quarter Variance Quarter Variance For years
: million baht April-June January-June 2019 2018 Variance 2019 2018 Variance MB % MB % Net profit (loss) for the period (698.1) (82.0) (616.1) (751.3) (187.2) 637.3 (824.5) (129.4) Plus: Finance Cost 429.6
2017; Table: Operating Results (Unit: Million Baht) Items Quarter Variance Quarter Variance For nine-month periods Variance 3/2018 2/2018 (%QoQ) 3/2017 (%YoY) 2018 2017 (%YoY) Net interest income 1,218.7
comparative performance of the third quarter of 2019 and the third quarter of 2018. Table: Operating Results (Unit: Million Baht) Items Quarter Variance Quarter Variance 9-month period Variance 3/2019 2/2019